Evidence map›Paper›PMID 27732643›Full record

ArticlePloS one2016

A High-Content Larval Zebrafish Brain Imaging Method for Small Molecule Drug Discovery.

Harrison Liu, Steven Chen, Kevin Huang, Jeffrey Kim, Han Mo, Raffael Iovine, Julie Gendre, Pauline Pascal, Qiang Li, Yaping Sun and 4 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Frontiers in pharmacology · 2022
    Article
  2. Observational
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Harrison LiuJoint Graduate Program in Bioengineering, University of California, San Francisco and University of California, Berkeley, California, United States of America.
Steven ChenSmall Molecule Discovery Center, University of California, San Francisco, San Francisco, California, United States of America.
Kevin HuangDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Jeffrey KimDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Han MoDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Raffael IovineDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Julie GendreDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Pauline PascalDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Qiang LiDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Yaping SunDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Zhiqiang DongDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Michelle ArkinSmall Molecule Discovery Center, University of California, San Francisco, San Francisco, California, United States of America.
Su GuoDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
Bo HuangDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America.ORCID http://orcid.org/0000-0003-1704-4141

Funding

PHARMACEUTICAL SCIENCES AND PHARMACOGENOMICST32GM007175 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AHITUV, NADAV, KROETZ, DEANNA L · 1985 to 2021
$7.1M
Microfluidic immunoprofiling for biomarker discovery in rheumatoid arthritisDP2AR068129 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ABATE, ADAM R. · 2014 to 2014
$2.4M
Advancing Whole-Organism Screening for Chemical Modifiers of the BrainR21NS082938 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ABATE, ADAM R., GUO, SU · 2013 to 2014
$410k
NIAMS NIH HHS DP2 AR068129NIGMS NIH HHS T32 GM007175NINDS NIH HHS R21 NS082938
6 · The paper itself

Abstract

Drug discovery in whole-organisms such as zebrafish is a promising approach for identifying biologically-relevant lead compounds. However, high content imaging of zebrafish at cellular resolution is challenging due to the difficulty in orienting larvae en masse such that the cell type of interest is in clear view. We report the development of the multi-pose imaging method, which uses 96-well round bottom plates combined with a standard liquid handler to repose the larvae within each well multiple times, such that an image in a specific orientation can be acquired. We have validated this method in a chemo-genetic zebrafish model of dopaminergic neuron degeneration. For this purpose, we have developed an analysis pipeline that identifies the larval brain in each image and then quantifies neuronal health in CellProfiler. Our method achieves a SSMD* score of 6.96 (robust Z'-factor of 0.56) and is suitable for screening libraries up to 105 compounds in size.

Indexed as

ZebrafishAnimalsBrainDopaminergic NeuronsDrug Evaluation, PreclinicalHigh-Throughput Screening AssaysLarvaMicroscopyNeuroimagingOptical ImagingSmall Molecule LibrariesSmall Molecule Libraries

Identifiers

PMID27732643
PMCPMC5061318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.